Keywords: ligand, retinoids, launch, double, assault, kaposi, sarcoma

Ligand Retinoids Launch Double Assault On Kaposi's Sarcoma

Article | 16 October 1995

Intracellular receptor specialist Ligand Pharmaceuticals is starting to see positive results from its anticancer program with the presentation of two ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Go to company listing

Related Drugs

bexarotene

Targretin

Nystatin

Alpha

Prolastin

Go to drug listing